Castellum (CTM) COO gets 275,000 options at $1.19; 20-month vest
Castellum (CTM) reported an insider equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Castellum (CTM) reported an insider equity grant. Chief Operating Officer Andrew Merriman was awarded 275,000 stock options on November 11, 2025 under the Second Amended 2021 Stock Incentive Plan at an exercise price of $1.19 per share. The options vest ratably over twenty months, beginning December 1, 2025, and expire on November 10, 2032. Following the grant, 275,000 derivative securities are beneficially owned directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 275,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. In connection with his continued employment, on November 11, 2025 Mr. Merriman received 275,000 stock options issued pursuant to the Castellum, Inc. Second Amended 2021 Stock Incentive Plan to purchase 275,000 shares of common stock, which vest ratably over twenty months, commencing December 1, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Castellum (CTM) disclose in this Form 4?
What is the vesting schedule for the CTM COO’s options?
What is the exercise price and expiration for the options?
How many derivative securities does the COO own after the transaction?
Under which plan were the options granted to CTM’s COO?
Who is the reporting person in this CTM Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.